RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing

Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequenci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Veronica Verdile, Gloria Guizzo, Gabriele Ferrante, Maria Paola Paronetto
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bfdf39e3e7f3450d90d8cdf0f18f3cf7
record_format dspace
spelling oai:doaj.org-article:bfdf39e3e7f3450d90d8cdf0f18f3cf72021-11-25T17:07:58ZRNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing10.3390/cells101128502073-4409https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf72021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2850https://doaj.org/toc/2073-4409Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequencing technologies has allowed identification of novel genes and mutations associated with neuromuscular pathologies, highlighting splicing defects as essential players. Deciphering the significance and relative contributions of defective RNA metabolism will be instrumental to address and counteract these malignancies. We review here recent progress on the role played by alternative splicing in ensuring functional neuromuscular junctions (NMJs), and its involvement in the pathogenesis of NMJ-related neuromuscular disorders, with particular emphasis on congenital myasthenic syndromes and muscular dystrophies. We will also discuss novel strategies based on oligonucleotides designed to bind their cognate sequences in the RNA or targeting intermediary of mRNA metabolism. These efforts resulted in several chemical classes of RNA molecules that have recently proven to be clinically effective, more potent and better tolerated than previous strategies.Veronica VerdileGloria GuizzoGabriele FerranteMaria Paola ParonettoMDPI AGarticlealternative splicingneuromuscular diseaseRNA-based therapiesBiology (General)QH301-705.5ENCells, Vol 10, Iss 2850, p 2850 (2021)
institution DOAJ
collection DOAJ
language EN
topic alternative splicing
neuromuscular disease
RNA-based therapies
Biology (General)
QH301-705.5
spellingShingle alternative splicing
neuromuscular disease
RNA-based therapies
Biology (General)
QH301-705.5
Veronica Verdile
Gloria Guizzo
Gabriele Ferrante
Maria Paola Paronetto
RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
description Neuromuscular disorders represent multifaceted abnormal conditions, with little or no cure, leading to patient deaths from complete muscle wasting and atrophy. Despite strong efforts in the past decades, development of effective treatments is still urgently needed. Advent of next-generation sequencing technologies has allowed identification of novel genes and mutations associated with neuromuscular pathologies, highlighting splicing defects as essential players. Deciphering the significance and relative contributions of defective RNA metabolism will be instrumental to address and counteract these malignancies. We review here recent progress on the role played by alternative splicing in ensuring functional neuromuscular junctions (NMJs), and its involvement in the pathogenesis of NMJ-related neuromuscular disorders, with particular emphasis on congenital myasthenic syndromes and muscular dystrophies. We will also discuss novel strategies based on oligonucleotides designed to bind their cognate sequences in the RNA or targeting intermediary of mRNA metabolism. These efforts resulted in several chemical classes of RNA molecules that have recently proven to be clinically effective, more potent and better tolerated than previous strategies.
format article
author Veronica Verdile
Gloria Guizzo
Gabriele Ferrante
Maria Paola Paronetto
author_facet Veronica Verdile
Gloria Guizzo
Gabriele Ferrante
Maria Paola Paronetto
author_sort Veronica Verdile
title RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
title_short RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
title_full RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
title_fullStr RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
title_full_unstemmed RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
title_sort rna targeting in inherited neuromuscular disorders: novel therapeutic strategies to counteract mis-splicing
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bfdf39e3e7f3450d90d8cdf0f18f3cf7
work_keys_str_mv AT veronicaverdile rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing
AT gloriaguizzo rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing
AT gabrieleferrante rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing
AT mariapaolaparonetto rnatargetingininheritedneuromusculardisordersnoveltherapeuticstrategiestocounteractmissplicing
_version_ 1718412739058073600